Xenical

How to order Xenical

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Xenical on Prescriptsy

Xenical is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Xenical is the brand name for orlistat 120 mg hard capsules, manufactured by Roche.

Orlistat is a gastrointestinal lipase inhibitor that reduces the absorption of dietary fat by approximately 30%, supporting weight loss when used alongside a reduced-calorie diet and increased physical activity.

Xenical is licensed for the treatment of obesity in adults with a body mass index (BMI) of 30 kg/m2 or above, or 28 kg/m2 or above with associated weight-related risk factors such as type 2 diabetes, hypertension, or dyslipidaemia.

It is a prescription-only medicine (POM) in the United Kingdom.

Obesity is one of the most significant public health challenges in the UK.

According to the Health Survey for England, approximately 26% of adults in England are classified as obese (BMI 30 or above) and a further 38% are overweight (BMI 25 to 29.9).

Obesity is a major risk factor for type 2 diabetes, cardiovascular disease, certain cancers (including breast, bowel, and endometrial), osteoarthritis, obstructive sleep apnoea, non-alcoholic fatty liver disease, and depression.

The NHS spends an estimated 6.5 billion pounds annually on overweight- and obesity-related conditions.

Effective pharmacological interventions alongside lifestyle modification are essential components of a comprehensive weight management strategy.

This page provides a detailed clinical guide to Xenical, covering how it works, dosage, side effects, safety warnings, and how to obtain it in the United Kingdom.

Important safety information about Xenical

Before reading further, note these essential safety points about Xenical.

• Xenical must be used alongside a reduced-calorie, lower-fat diet. It is not effective without dietary modification.
• Take a daily multivitamin (containing vitamins A, D, E, K) at bedtime or at least 2 hours apart from Xenical.
• Treatment should be stopped after 12 weeks if you have not lost at least 5% of your starting body weight.
• Xenical reduces the absorption of several important medications including levothyroxine and ciclosporin.
• Seek medical attention immediately if you develop jaundice, dark urine, or abdominal pain.

Understanding obesity and weight management

Obesity is defined as a BMI of 30 kg/m2 or above. It results from a chronic energy imbalance where calorie intake exceeds energy expenditure over a sustained period.

The pathophysiology is complex, involving genetic predisposition (heritability estimates of 40 to 70%), neuroendocrine regulation of appetite and satiety (including leptin, ghrelin, insulin, and glucagon-like peptide-1 signalling), environmental factors (food availability, energy-dense diets, sedentary behaviour), psychological factors, socioeconomic determinants, and the gut microbiome.

NICE guideline CG189 on obesity recommends a structured approach to weight management.

First-line treatment is always multicomponent lifestyle intervention: dietary modification (a 600 kcal/day deficit from estimated requirements), increased physical activity (at least 150 minutes of moderate-intensity activity per week), and behavioural strategies.

Pharmacotherapy is considered when lifestyle interventions alone have not achieved clinically meaningful weight loss (at least 5% of initial body weight) after 3 to 6 months, and BMI criteria are met.

Bariatric surgery is reserved for BMI 40 or above (or 35 or above with comorbidities) when other measures have failed.

How Xenical works

Orlistat is a potent, specific, and reversible inhibitor of gastrointestinal lipases. Dietary fat (triglycerides) cannot be absorbed intact across the intestinal mucosa.

It must first be hydrolysed by gastric lipase (secreted by chief cells in the stomach) and pancreatic lipase (secreted by the exocrine pancreas into the duodenum) into free fatty acids and 2-monoacylglycerol, which can then be absorbed by intestinal enterocytes.

Orlistat forms a covalent bond with the active serine residue on the catalytic site of these lipases, rendering them permanently inactive. Each orlistat molecule inactivates one lipase molecule.

At the therapeutic dose of 120 mg three times daily, orlistat inhibits approximately 30% of dietary fat absorption.

The undigested triglycerides remain in the intestinal lumen and are excreted in the faeces, creating a calorie deficit.

If a patient consumes 80 grams of fat daily (720 kcal from fat), orlistat prevents absorption of approximately 24 grams (216 kcal), contributing to weight loss over time.

Orlistat acts entirely within the gastrointestinal lumen with negligible systemic absorption (less than 1% of the dose reaches the systemic circulation).

This local mechanism of action means it does not affect central nervous system appetite regulation and has no stimulant, sedative, or cardiovascular effects, distinguishing it from centrally acting weight-loss medications.

Any absorbed orlistat is rapidly metabolised and eliminated primarily through bile.

Clinical evidence for Xenical

The efficacy of orlistat 120 mg three times daily has been demonstrated in multiple randomised controlled trials.

The XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study was a landmark 4-year, double-blind trial involving 3,305 obese patients, which demonstrated that orlistat plus lifestyle changes resulted in significantly greater weight loss than lifestyle changes alone (5.8 kg versus 3.0 kg mean weight loss at 4 years).

The XENDOS trial also showed a 37.3% reduction in the incidence of type 2 diabetes in the orlistat group compared with placebo, an effect largely mediated by weight loss.

Additional benefits included reductions in total cholesterol, LDL cholesterol, blood pressure, and waist circumference.

A Cochrane systematic review of 16 randomised controlled trials involving over 10,000 participants concluded that orlistat 120 mg three times daily produced a weighted mean difference in weight loss of 2.9 kg greater than placebo at 12 months.

The review also confirmed improvements in cardiovascular risk factors including total cholesterol, LDL cholesterol, blood pressure, and fasting glucose.

Dosage and administration

Take one Xenical 120 mg capsule with water immediately before, during, or up to 1 hour after each main meal containing fat, up to a maximum of 3 capsules daily.

If a meal is missed or contains no fat, skip the dose.

The calorie intake from fat should be distributed approximately evenly across the 3 main meals, aiming for roughly 30% of total calories from fat (approximately 60 to 70 grams of fat per day for most adults).

Treatment efficacy should be assessed at 12 weeks.

If the patient has not achieved at least 5% weight loss from baseline, Xenical should be discontinued, as continued treatment is unlikely to produce clinically meaningful results.

If weight loss targets are met, treatment may continue for up to 2 years based on XENDOS trial data, with regular review by the prescriber.

A daily multivitamin containing fat-soluble vitamins A, D, E, and K is recommended to offset reduced absorption.

The multivitamin should be taken at bedtime or at least 2 hours before or after the Xenical dose.

Patients should also maintain adequate calcium and vitamin D intake for bone health, as long-term fat malabsorption can contribute to osteoporosis risk.

Side effects of Xenical

Gastrointestinal side effects

Gastrointestinal symptoms are the most common adverse effects and are a direct pharmacological consequence of undigested fat in the bowel.

They are more frequent and severe when dietary fat intake is high, serving as a built-in reinforcement mechanism for dietary compliance.

Oily spotting from the rectum is the most characteristic effect, reported by up to 27% of patients in clinical trials.

Flatus with oily discharge, faecal urgency, fatty or oily stools (steatorrhoea), increased defecation frequency, and oily evacuation are all very common.

These effects typically peak during the first few weeks of treatment and diminish as patients learn to moderate fat intake.

Faecal incontinence is reported in approximately 6% of patients and can be socially distressing.

Other side effects

Headache, upper respiratory tract infection, influenza-like symptoms, and urinary tract infections are commonly reported but may not be directly attributable to orlistat. Irregular menstrual periods have been reported.

Anxiety and hypoglycaemia (in patients with type 2 diabetes) are uncommon.

Reduced absorption of fat-soluble vitamins is well documented and clinically significant deficiency can develop without supplementation, particularly vitamin D deficiency in the UK population where baseline levels are already suboptimal.

Rare but serious side effects

Hepatotoxicity including elevated transaminases, hepatitis, and very rarely hepatic failure has been reported. The mechanism is uncertain.

Patients should seek immediate medical attention if they develop jaundice, dark urine, pale stools, pruritus, or right upper quadrant pain. Pancreatitis has been reported rarely.

Oxalate nephropathy (kidney damage from increased urinary oxalate excretion) has been reported, particularly in patients with underlying renal disease or dehydration.

Severe allergic reactions including anaphylaxis are very rare. Report suspected adverse reactions to the MHRA at yellowcard.mhra.gov.uk .

Warnings and precautions

Contraindications

Xenical is contraindicated in chronic malabsorption syndrome, cholestasis, known hypersensitivity to orlistat or any excipient, concurrent ciclosporin use, pregnancy, and breastfeeding. It should not be used in children under 18 years of age.

Drug interactions

Ciclosporin: concomitant use is contraindicated because orlistat reduces ciclosporin absorption by up to 50%, risking transplant rejection.

If orlistat and ciclosporin must be used, the MHRA advises separating doses by at least 3 hours and increasing ciclosporin monitoring, though this combination remains generally inadvisable.

Levothyroxine: take at least 4 hours apart from orlistat, and monitor thyroid function tests as hypothyroidism may worsen.

Warfarin: monitor INR closely as altered vitamin K absorption may affect anticoagulation. Antiepileptic drugs (valproate, lamotrigine, topiramate): reduced absorption may lower plasma levels and increase seizure risk.

Oral contraceptives: use additional barrier contraception if severe diarrhoea occurs. Amiodarone: reduced absorption has been reported.

Special populations

Patients with type 2 diabetes should monitor blood glucose more frequently when starting Xenical, as weight loss may necessitate dose reductions of oral hypoglycaemic agents or insulin.

Patients with a history of calcium oxalate nephrolithiasis should maintain adequate hydration and be monitored for renal function.

Patients with hypothyroidism taking levothyroxine require increased monitoring of thyroid function.

Older adults may use Xenical at standard doses; however, clinical trial data in patients over 65 years are limited.

How to get Xenical in the UK

Xenical (orlistat 120 mg) is available on NHS prescription from your GP or an authorised online prescriber registered with the General Pharmaceutical Council (GPhC).

NICE guideline CG189 recommends pharmacotherapy for obesity when BMI is 30 or above (or 28 or above with comorbidities) and lifestyle interventions have been insufficient.

Generic orlistat 120 mg capsules are also available and are bioequivalent.

The standard NHS prescription charge in England is 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

Orlistat 60 mg is available without prescription as the pharmacy medicine (P) brand Alli.

Sources

• Xenical 120 mg, Summary of Product Characteristics (EMC)
• Orlistat, British National Formulary (BNF)
• NICE CG189: Obesity, identification, assessment and management
• Obesity, NICE CKS
• Orlistat, NHS
• MHRA Yellow Card Scheme